Româo J E, Fadil M A, Sabbaga E, Marcondes M
Nephrology Division, Hospital das Clínicas, University of São Paulo School of Medicine, Brazil.
Nephrol Dial Transplant. 1997 Jan;12(1):106-10. doi: 10.1093/ndt/12.1.106.
Haemodialysis without anticoagulant is an alternative to systemic anticoagulation of patients at high risk of bleeding. However, reports have suggested that heparin-free haemodialysis might results in blood defibrination, and fibrin deposition in dialytic membrane with possible reduction in dialyser efficiency.
Haemostasis parameters, fibrin-fibrinogen kinetic assessed by 125I-fibrinogen (125I-F) turnover and 125I-fibrinogen deposition within the dialyser membranes, and dialytic efficiency were studied in 10 stable chronic uraemic patients. Each patient was dialysed on two consecutive 4-h dialyses, once with each of two dialysis strategies: haemodialysis without anticoagulant and conventional haemodialysis using heparin as anticoagulant.
No significant changes were seen in mean platelet count, plasma fibrinogen, prothrombin time, and antithrombin III during haemodialysis without anticoagulation, and these parameters were not different from those in patients who underwent conventional haemodialysis. Compared with the predialysis values, a shortening of the mean aPTT from an initial mean value was noted (P < 0.05) in haemodialysis without anticoagulation at 60, 120 and 240 min. Fibrin-fibrinogen degradation products remained unchanged during conventional haemodialysis, but were increased after the 30th minute of haemodialysis without anticoagulation (P < 0.05), although all values were in normal range. The biological half-life of 125I-F in uraemic patients before the haemodialysis was 5.02 +/- 0.43 days (control). There was a significant fall in 125I-F half-life during haemodialysis without anticoagulation (2.56 +/- 0.58 days; P < 0.01) but not during conventional haemodialysis (4.77 +/- 0.97, NS). After use each dialyser was dismantled and 125I-F deposition within the membranes (M#5, M#12 and M#19) was measured. During haemodialysis without anticoagulation mean fibrin deposition in M# (28.74 +/- 10.50 x 10(3) counts), M#12 (26.42 +/- 9.06 x 10(3) counts), and M#19 (21.97 +/- 8.33 x 10(3) counts) was greater (P < 0.001) than that during conventional haemodialysis (1.70 +/- 0.92 x 10(3), 1.33 +/- 0.65 x 10(3), and 1.59 +/- 1.03 x 10(3) counts respectively). However, this greater deposition of fibrin on membranes during haemodialysis without anticoagulation did not change dialyser efficiency as assessed (haemodialysis without anticoagulation vs conventional haemodialysis) by change in serum urea (-53.96 +/- 3.38% vs -51.96 +/- 5.20%, NS), serum creatinine (-48.65 +/- 5.99% vs -49.59 +/- 6.65%, NS), serum potassium (-30.06 +/- 4.46% vs -27.64 +/- 2.81%, NS), serum bicarbonate (+25.91 +/- 1.39% vs +24.89 +/- 2.59%, NS) and haematocrit (+3.20 +/- 3.99% vs 2.15 +/- 2.01%, NS). The mean Kt/V was similar for conventional haemodialysis (0.870 +/- 0.074) and haemodialysis without anticoagulation (0.873 +/- 0.107).
In conclusion, although conventional haemostasis parameters remained unchanged during haemodialysis without anticoagulation, some degree of activation of coagulation system occurs, haemodialysis without anticoagulation was associated with greater decline in 125I-F half-life and greater fibrin deposition on dialyser membranes, but with no change in dialyser efficiency.
无抗凝剂血液透析是出血高风险患者全身抗凝的一种替代方法。然而,有报告表明,无肝素血液透析可能导致血液去纤维蛋白化,以及纤维蛋白在透析膜上沉积,可能降低透析器效率。
对10例稳定的慢性尿毒症患者进行止血参数、通过125I-纤维蛋白原(125I-F)周转评估的纤维蛋白-纤维蛋白原动力学、透析器膜内125I-纤维蛋白原沉积以及透析效率的研究。每位患者连续进行两次4小时透析,每种透析策略各进行一次:无抗凝剂血液透析和使用肝素作为抗凝剂的常规血液透析。
无抗凝剂血液透析期间,平均血小板计数、血浆纤维蛋白原、凝血酶原时间和抗凝血酶III无显著变化,这些参数与接受常规血液透析的患者无差异。与透析前值相比,无抗凝剂血液透析在60、120和240分钟时平均活化部分凝血活酶时间(aPTT)较初始平均值缩短(P<0.05)。常规血液透析期间纤维蛋白-纤维蛋白原降解产物保持不变,但无抗凝剂血液透析30分钟后增加(P<0.05),尽管所有值均在正常范围内。血液透析前尿毒症患者125I-F的生物半衰期为5.02±0.43天(对照)。无抗凝剂血液透析期间125I-F半衰期显著下降(2.56±0.58天;P<0.01),而常规血液透析期间无下降(4.77±0.97,无显著性差异)。每次使用后拆解透析器并测量膜内(M#5、M#12和M#19)125I-F沉积。无抗凝剂血液透析期间,M#(28.74±10.50×10(3)计数)、M#12(26.42±9.06×10(3)计数)和M#19(21.97±8.33×10(3)计数)的平均纤维蛋白沉积量比常规血液透析期间(分别为1.70±0.92×10(3)、1.33±0.65×10(3)和1.59±1.03×10(3)计数)更大(P<0.001)。然而,无抗凝剂血液透析期间纤维蛋白在膜上的这种更大沉积并未改变通过血清尿素变化(-53.96±3.38%对-51.96±5.20%,无显著性差异)、血清肌酐(-48.65±5.99%对-49.59±6.65%,无显著性差异)、血清钾(-30.06±4.46%对-27.64±2.81%,无显著性差异)、血清碳酸氢盐(+25.91±1.39%对+24.89±2.59%,无显著性差异)和血细胞比容(+3.20±3.99%对2.15±2.01%,无显著性差异)评估的透析器效率。常规血液透析(0.870±0.074)和无抗凝剂血液透析(0.873±0.107)的平均Kt/V相似。
总之,尽管无抗凝剂血液透析期间常规止血参数保持不变,但凝血系统发生了一定程度的激活,无抗凝剂血液透析与125I-F半衰期更大程度下降和透析器膜上纤维蛋白沉积增多相关,但透析器效率无变化。